The Current State of Neoadjuvant Therapy in Resectable Advanced Stage Melanoma

The advent of effective immunotherapy and targeted therapy has significantly improved outcomes in advanced-stage resectable melanoma. Currently, the mainstay of treatment of malignant melanoma is surgery followed by adjuvant systemic therapies. However, recent studies have shown a potential role for...

Full description

Bibliographic Details
Main Authors: Omar Bushara, Jerica Tidwell, James R. Wester, John Miura
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/13/3344